OvaCure Innovation Summit & Collaboration Labs

OvaCure brings together scientists, clinicians and researchers from around the globe annual to co-create, collaborate and innovate ovarian cancer treatment approaches

OvaCure brings together scientists, clinicians and researchers from around the globe annual to co-create, collaborate and innovate ovarian cancer treatment approaches

The annual OvaCure Innovation Summits bring together leading international experts within ovarian cancer, immunotherapy, oncology and innovative technologies. At the summit, experts provide inspiration for and collaborate to develop clinical projects with the greatest potential to cure. OvaCure's Scientific and Clinical Advisory Board then co-create, innovate and invest in new research projects focusing on treatments with breakthrough potential to cure ovarian cancer. Specific criteria for selecting the participants ensures the highest level of expertise applied to each project. Research projects nominated must have the potential to be studied in clinical trials within a reasonable time frame, ensuring an efficient streamline from the laboratory to the patient.

In 2016 OvaCure launched the first Collaboration Labs, dedicated to accelerate existing pipeline projects. The labs offer international clinicians and researchers to further define the clinical design needed to initiate their projects. 

OvaCure Scientific and Clinical Advisory Board is committed to optimising the projects while OvaCure and Anticancer Fund are responsible for project managing. This ensures optimal and efficient use of funding. Results are reported and evaluated upon achieved milestone timelines. Projects supported by OvaCure are carried out at research centres where operations, personnel and facilities are already established with medical infrastructure as well as quality compliance systems.

 

OvaCure's Results to date

Screenshot 2016-12-07 21.35.59.png

Themes & Outcomes of OvaCure Innovation Summits and Collaboration Labs:

Summit theme 2014:

"To identify and develop high quality projects within immunotherapy and ovarian cancer and assist the implementation of relevant scientific research."

  • Development of "T-cell Infusion Project", launched in 2014

Summit theme 2015:

"Innovative Immunotherapy in Ovarian Cancer including combination and monotherapy."

  • Development of "T-cell Combination Project", launched in 2015
  • Development of "Personal T-cell Project", launched in 2015
  • Development of "Personal Vaccine Project", launched in 2016

SUMMIT THEME 2016:

“Innovative Personalised Immunotherapy Approaches in Ovarian Cancer”.

  • A new potential project is identified and in the process of being developed

Collaboration Lab 2016:

 “Can genetic screening of ovarian cancer patients lead to curative treatment options?”

  • Development of "Genetic-Match Project", launching at the end of 2016

Collaboration Lab 2016:

“Combined approaches in ovarian cancer - novel peptide vaccines, clinical antibodies and ACT with TILs.”